Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey M Sobell

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Seminars in Cutaneous Medicine and Surgery|September 15, 2018
Using targeted therapies for inflammatory dermatosesJeffrey M Sobell
Seminars in Cutaneous Medicine and Surgery|May 20, 2005
Overview of biologic agents in medicine and dermatologyJeffrey M Sobell
Seminars in Cutaneous Medicine and Surgery|August 19, 2016
Update on TNF Inhibitors in DermatologyJeffrey M Sobell
Seminars in Cutaneous Medicine and Surgery|October 1, 2014
The role of TNF inhibitors in psoriatic diseaseBrian F Mandell, Jeffrey M Sobell
Journal of Drugs in Dermatology : JDD|March 11, 2009
Patient fatalities potentially associated with efalizumab useJeffrey M Sobell, Jeffrey M Weinberg
Seminars in Cutaneous Medicine and Surgery|November 2, 2013
Introduction. DermatitisBrooke C Sikora, Jeffrey M Sobell
Seminars in Cutaneous Medicine and Surgery|October 1, 2014
Therapeutic development in psoriasisJeffrey M Sobell, Craig L Leonardi
Seminars in Cutaneous Medicine and Surgery|December 3, 2003
Systemic therapies for psoriasis: understanding current and newly emerging therapiesJeffrey M Sobell, Stephen J Hallas
Archives of Dermatology|March 22, 2006
Successful treatment of a widespread inflammatory verrucous epidermal nevus with etanerceptMelissa A Bogle, Jeffrey M Sobell, Jeffrey S Dover
Journal of Drugs in Dermatology : JDD|March 11, 2009
Management of moderate to severe plaque psoriasis (part 2): clinical update on T-cell modulators and investigational agentsJeffrey M Sobell, Robert E Kalb, Jeffrey M Weinberg
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Seminars in Cutaneous Medicine and Surgery|September 15, 2018
Using targeted therapies for inflammatory dermatosesJeffrey M Sobell
Seminars in Cutaneous Medicine and Surgery|May 20, 2005
Overview of biologic agents in medicine and dermatologyJeffrey M Sobell
Seminars in Cutaneous Medicine and Surgery|August 19, 2016
Update on TNF Inhibitors in DermatologyJeffrey M Sobell
Seminars in Cutaneous Medicine and Surgery|October 1, 2014
The role of TNF inhibitors in psoriatic diseaseBrian F Mandell, Jeffrey M Sobell
Journal of Drugs in Dermatology : JDD|March 11, 2009
Patient fatalities potentially associated with efalizumab useJeffrey M Sobell, Jeffrey M Weinberg
Seminars in Cutaneous Medicine and Surgery|November 2, 2013
Introduction. DermatitisBrooke C Sikora, Jeffrey M Sobell
Seminars in Cutaneous Medicine and Surgery|October 1, 2014
Therapeutic development in psoriasisJeffrey M Sobell, Craig L Leonardi
Seminars in Cutaneous Medicine and Surgery|December 3, 2003
Systemic therapies for psoriasis: understanding current and newly emerging therapiesJeffrey M Sobell, Stephen J Hallas
Archives of Dermatology|March 22, 2006
Successful treatment of a widespread inflammatory verrucous epidermal nevus with etanerceptMelissa A Bogle, Jeffrey M Sobell, Jeffrey S Dover
Journal of Drugs in Dermatology : JDD|March 11, 2009
Management of moderate to severe plaque psoriasis (part 2): clinical update on T-cell modulators and investigational agentsJeffrey M Sobell, Robert E Kalb, Jeffrey M Weinberg
Pageof 2